These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11704746)

  • 1. [Monitoring and prophylaxis].
    Yoshida M
    Nihon Ishinkin Gakkai Zasshi; 2001; 42(4):205-10. PubMed ID: 11704746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of serum human Galactomannan aspergillus antigen and 1,3-beta-D-glucan in immunocompromised patient suspected fungal infection.
    Susianti H; Parmadi L; Firani NK; Setyawan UA; Sartono TR
    J Clin Lab Anal; 2021 Jun; 35(6):e23806. PubMed ID: 33945177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of fungal infection: new technologies for the mycology laboratory.
    Alexander BD
    Transpl Infect Dis; 2002; 4 Suppl 3():32-7. PubMed ID: 12486790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma (1-->3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes.
    Obayashi T; Yoshida M; Mori T; Goto H; Yasuoka A; Iwasaki H; Teshima H; Kohno S; Horiuchi A; Ito A
    Lancet; 1995 Jan; 345(8941):17-20. PubMed ID: 7799700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The performance of (1, 3)-beta-D-glucan and Aspergillus galactomannan measurement for early diagnosis of invasive aspergillosis in patients with hematological diseases].
    Horiguchi Y
    Kansenshogaku Zasshi; 2004 Jul; 78(7):566-73. PubMed ID: 15359888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interaction between piperacillin/tazobactam and assays for Aspergillus galactomannan and 1,3-beta-D-glucan in patients without risk factors for invasive fungal infections.
    Metan G; Ağkuş C; Buldu H; Koç AN
    Infection; 2010 Jun; 38(3):217-21. PubMed ID: 20237947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of 1,3-β-d-glucan with galactomannan in serum and bronchoalveolar fluid for the detection of Aspergillus species in immunosuppressed mechanical ventilated critically ill patients.
    Lahmer T; Neuenhahn M; Held J; Rasch S; Schmid RM; Huber W
    J Crit Care; 2016 Dec; 36():259-264. PubMed ID: 27475024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adult living-donor liver transplantation for a recipient with a high preoperative 1,3-beta-D-glucan level and positive test result for Aspergillus antigen.
    Takano K; Shimazu M; Chiba N; Iwamoto H; Nakamura Y; Konno O; Sano T; Fujii T; Serizawa H; Kawachi S
    Transplant Proc; 2015 Apr; 47(3):799-803. PubMed ID: 25724252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1-->3)-beta-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders.
    Kawazu M; Kanda Y; Nannya Y; Aoki K; Kurokawa M; Chiba S; Motokura T; Hirai H; Ogawa S
    J Clin Microbiol; 2004 Jun; 42(6):2733-41. PubMed ID: 15184460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma (1-->3)-beta-D-glucan and fungal antigenemia in patients with candidemia, aspergillosis, and cryptococcosis.
    Miyazaki T; Kohno S; Mitsutake K; Maesaki S; Tanaka K; Ishikawa N; Hara K
    J Clin Microbiol; 1995 Dec; 33(12):3115-8. PubMed ID: 8586684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serodiagnosis for deep-seated mycoses].
    Maesaki S
    Nihon Ishinkin Gakkai Zasshi; 2002; 43(4):233-7. PubMed ID: 12402024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introducing 1,3-beta-d-glucan for screening and diagnosis of invasive fungal diseases in Australian high-risk haematology patients: is there a clinical benefit?
    Garnham K; Halliday CL; Rai NJ; Jayawardena M; Hasan T; Kok J; Nayyar V; Gottlieb DJ; Gilroy NM; Chen SC
    Intern Med J; 2022 Mar; 52(3):426-435. PubMed ID: 32896984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative evaluation of pan-fungal real-time PCR, galactomannan and (1-3)-β-D-glucan assay for invasive fungal infection in paediatric cancer patients.
    Gupta P; Ahmad A; Khare V; Kumar A; Banerjee G; Verma N; Singh M
    Mycoses; 2017 Apr; 60(4):234-240. PubMed ID: 27862370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of mycoses in surgical patients -- review of the literature.
    Holzheimer RG; Dralle H
    Eur J Med Res; 2002 May; 7(5):200-26. PubMed ID: 12069912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sero-diagnosis for pulmonary aspergillosis--its utility in early diagnosis].
    Niki Y
    Rinsho Byori; 1996 Jun; 44(6):518-23. PubMed ID: 8752728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serologic biomarkers in Candida and Aspergillus infections of the central nervous system: A comparison of galactomannan, mannan and β-1,3-D-gucan testing from serum and cerebrospinal fluid.
    Forster J; Hoenigl M; Suerbaum S; Wagener J; Dichtl K
    Mycoses; 2022 Jul; 65(7):709-714. PubMed ID: 35506957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preemptive treatment of fungal infection based on plasma (1 --> 3)beta-D-glucan levels after liver transplantation.
    Akamatsu N; Sugawara Y; Kaneko J; Tamura S; Makuuchi M
    Infection; 2007 Oct; 35(5):346-51. PubMed ID: 17885729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of plasma (1-->3)-beta-D-glucan measurement by the kinetic turbidimetric Limulus test, for the clinical diagnosis of mycotic infections.
    Mori T; Ikemoto H; Matsumura M; Yoshida M; Inada K; Endo S; Ito A; Watanabe S; Yamaguchi H; Mitsuya M; Kodama M; Tani T; Yokota T; Kobayashi T; Kambayashi J; Nakamura T; Masaoka T; Teshima H; Yoshinaga T; Kohno S; Hara K; Miyazaki S
    Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):553-60. PubMed ID: 9263735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [1,3-Beta-D-glucan measurement and its usefulness in the diagnosis of invasive fungal infections].
    Kocmanová I; Rácil Z; Koukalová D; Mayer J
    Klin Mikrobiol Infekc Lek; 2008 Jun; 14(3):88-92. PubMed ID: 18688768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current trends in the detection of antigenaemia, metabolites and cell wall markers for the diagnosis and therapeutic monitoring of fungal infections.
    Verweij PE; Poulain D; Obayashi T; Patterson TF; Denning DW; Ponton J
    Med Mycol; 1998; 36 Suppl 1():146-55. PubMed ID: 9988503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.